Determining the incidence and change in severity of peripheral neuropathy upon retreatment of multiple myeloma patients with bortezomib as compared to initial bortezomib treatment

Clinical Program: Malignant Hematology Program
Primary Sponsor: Oncotherapeutics
Principal Investigator: Imad Tabbara
Contact Info: 202-741-2981